l9n/ Connecticut

2025 Regular Session

Senate Bill 1473

AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

Became law as Public Act 25-63, signed June 23, 2025, 109 days after it was filed.

What it does

The synopsis the General Assembly published with the bill.

To require Medicaid coverage for gene therapies approved by the federal Food and Drug Administration to treat sickle cell disease.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

Its course

March 6 to June 23, 2025, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action18 actions on 12 days

In the SenateMar 6 to May 156 days

Human Services CommitteeMar 6 to Mar 148 days

In the House of RepresentativesMay 1 to May 3130 days

Waiting to be sentMay 31 to Jun 99 days

With the GovernorJun 9 to Jun 2314 days

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the Senate Mar 6 โ€“ May 1

  1. Introduced and sent to Human Services Committee
  2. Heard in Human Services Committee
  3. Human Services Committee recommended it
  4. Passed the Senate

In the House of Representatives May 2 โ€“ May 31

  1. Arrived in the House of Representatives
  2. Passed the House of Representatives

To the Governor Jun 3 โ€“ Jun 23

  1. Numbered Public Act 25-63
  2. Sent to the Secretary of the State
  3. Sent to the Governor
  4. Signed by the Governor
All 18 actions, as published